NCT07182045Recruiting

Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.

Source: ClinicalTrials.gov · Last updated 14 May 2026

Brief summary (registry, in English)

This study hypothesizes that temporary bilateral uterine and utero-ovarian artery occlusion with laparoscopic clamps at time of minimally invasive myomectomy will lead to a decreased blood loss at time of myomectomy compared to minimally invasive myomectomy without temporary occlusion.

Status (registry): Recruiting
Study type: Interventional
Enrollment: 120 (estimated)
First submitted: 16 Sept 2025
Start date: Sept 2025
Primary completion date: Sept 2028
Lead sponsor: The University of Texas Health Science Center, Houston
NCT number: NCT07182045

What you commit to

Study type: Interventional
Planned participants: 120
From Sept 2025 to the primary completion date, Sept 2028
1 site in 1 country
Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

Patients undergoing concomitant surgery such as endometriosis surgery,

Other illness

Suspected malignancy

Age

Age \<18yo,

Other

Pregnancy,

Who the study is looking for

Patient undergoing minimally invasive myomectomy with either a single intramural or Submucosal fibroid =/\>5cm or
Patients undergoing minimally invasive Myomectomy with =/\> 5 fibroids

Age in the registry: 18 years to - · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

Site	City	Country	Site status
Memorial Hermann Hospital Coordinator of this site? Confirm its status	Houston	United States	Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.